Medifast (NYSE:MED) Updates FY23 Earnings Guidance

Medifast (NYSE:MED – Get Free Report) updated its FY23 earnings guidance on Monday. The company provided earnings per share guidance of $8.65-$9.55 for the period, compared to the consensus earnings per share estimate of $8.53. The company issued revenue guidance of $1.05-$1.07 billion, compared to the consensus revenue estimate of $1.09 billion. Wall Street Analyst […]

Related Keywords

United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Constancej Hallquist ,Jeffreyj Brown , ,Medifast Company Profile ,Hightower Advisors ,Optimal Health ,Citigroup Inc ,Cetera Advisor Networks ,Medifast Inc ,Raymond James Associates ,Securities Exchange Commission ,Cambridge Investment Research Advisors Inc ,Get Free Report ,Director Constance ,Exchange Commission ,Director Jeffrey ,Investment Research Advisors ,Tower Advisors ,Advisor Networks ,Take Shape ,Medifast Daily ,Medifast ,Nyse Med ,Amed ,Consumer Cyclical ,58470h10 ,Guidance ,Earnings ,Preannouncement ,